 CAMBRIDGE, Mass.--BUSINESS WIRE--Scholar Rock NASDAQ: SRRK, a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced that management will participate in an Orphan Neuro and Neuromuscular panel discussion at Cowens 42nd Annual Health Care Conference on Monday, March 7, 2022 at 9:10 a.m. ET. A live webcast of the presentation may be accessed by visiting the Investors Media section of 